Literature DB >> 33838291

Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis.

Huxinyue Duan1, Qing Zhang1, Jia Liu1, Ruolan Li1, Dan Wang1, Wei Peng2, Chunjie Wu3.   

Abstract

Atherosclerosis, a chronic multifactorial disease, is closely related to the development of cardiovascular diseases and is one of the predominant causes of death worldwide. Normal vascular endothelial cells play an important role in maintaining vascular homeostasis and inhibiting atherosclerosis by regulating vascular tension, preventing thrombosis and regulating inflammation. Currently, accumulating evidence has revealed that endothelial cell apoptosis is the first step of atherosclerosis. Excess apoptosis of endothelial cells induced by risk factors for atherosclerosis is a preliminary event in atherosclerosis development and might be a target for preventing and treating atherosclerosis. Interestingly, accumulating evidence shows that natural medicines have great potential to treat atherosclerosis by inhibiting endothelial cell apoptosis. Therefore, this paper reviewed current studies on the inhibitory effect of natural medicines on endothelial cell apoptosis and summarized the risk factors that may induce endothelial cell apoptosis, including oxidized low-density lipoprotein (ox-LDL), reactive oxygen species (ROS), angiotensin II (Ang II), tumor necrosis factor-α (TNF-α), homocysteine (Hcy) and lipopolysaccharide (LPS). We expect this review to highlight the importance of natural medicines, including extracts and monomers, in the treatment of atherosclerosis by inhibiting endothelial cell apoptosis and provide a foundation for the development of potential antiatherosclerotic drugs from natural medicines.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (-)-Epigallocatechin-3-gallate (PubChem CID: 65064); 2,3,5,4’-tetrahydroxystilbene-2-O-β-D-glucoside (PubChem CID: 6438627); 3β-Hydroxyolean-12-en-28-oic acid (PubChem CID: 3010929); 6-Shogaol (PubChem CID: 5281794); Akebia Saponin D (PubChem CID: 14284436); Allicin (PubChem CID: 65036); Apigenin (PubChem CID: 5280443); Apoptosis; Atherosclerosis; Blueberry anthocyanin (PubChem CID: 135327637); Capsaicin (PubChem CID: 1548943); Catalpol (PubChem CID: 91520); Celastrol (PubChem CID: 122724); Chicoric acid (PubChem CID: 5281764); Cinnamaldehyde (PubChem CID: 637511); Cyanidin (PubChem CID: 128861); Cyanidin-3-O-β-glucoside (PubChem CID: 441667); Cycloartenyl ferulate (PubChem CID: 5282164); Dihydromyricetin (PubChem CID: 161557); Dioscin (PubChem CID: 119245); Elatoside C (PubChem CID: 101658259); Ellagic acid (PubChem CID: 5281855); Farrerol (PubChem CID: 91144); Folic acid (PubChem CID: 135398658); Genistein (PubChem CID: 5280961); Ginkgolide B (PubChem CID: 65243); Ginsenoside Rb1 (PubChem CID: 9898279); Ginsenoside compound K (PubChem CID: 9852086); Gypenoside XVⅡ (PubChem CID: 11968565); Hyperin (PubChem CID: 5281643); Isoquercitrin (PubChem CID: 5280804); Kaempferol (PubChem CID: 5280863); Ligustrazine (PubChem CID: 14296); Lunasin (PubChem CID: 20054959); Lycopene (PubChem CID: 446925); Myricitrin (PubChem CID: 5281673); Naringenin (PubChem CID: 932); Natural medicines; Notoginsenoside Fc (PubChem CID: 75412556); Notoginsenoside R1 (PubChem CID: 441934); Oxymatrine (PubChem CID: 114850); Paeoniflorin (PubChem CID: 442534); Paeonol (PubChem CID: 11092); Peonidin-3-O-β-glucoside (PubChem CID: 14311151); Picroside Ⅱ (PubChem CID: 11944602); Pinocembrin (PubChem CID: 68071); Protocatechuic Aldehyde (PubChem CID: 528594); Quercetin (PubChem CID: 5280343); Resveratrol (PubChem CID: 445154); Rhein (PubChem CID: 10168); Safflor yellow B (PubChem CID: 131751452); Schisandrin B (PubChem CID: 108130); Scutellarin (PubChem CID: 185617); Vaccarin (PubChem CID: 71307582); Vascular endothelial cells; α-Zearalanol (PubChem CID: 2999413)

Mesh:

Substances:

Year:  2021        PMID: 33838291     DOI: 10.1016/j.phrs.2021.105599

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  17 in total

1.  A Novel Peptide Isolated from Microalgae Isochrysis zhanjiangensis Exhibits Anti-apoptosis and Anti-inflammation in Ox-LDL Induced HUVEC to Improve Atherosclerosis.

Authors:  Yu Pei; Yi Lui; Shengxuan Cai; Chunxia Zhou; Pengzhi Hong; Zhong-Ji Qian
Journal:  Plant Foods Hum Nutr       Date:  2022-04-27       Impact factor: 3.921

2.  Induction of PI3K/Akt-Mediated Apoptosis in Osteoclasts Is a Key Approach for Buxue Tongluo Pills to Treat Osteonecrosis of the Femoral Head.

Authors:  Dan Wang; Yicheng Liu; Dandan Tang; Shujun Wei; Jiayi Sun; Lvqiang Ruan; Lin He; Ruolan Li; Qiang Ren; Xiaoping Tian; Yunhui Chen
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

3.  Recombinant human erythropoietin attenuates hepatic dysfunction by suppressing hepatocellular apoptosis in lipopolysaccharide-induced disseminated intravascular coagulation in rats.

Authors:  Yukio Suga; Fumio Akita; Shinya Yamada; Eriko Morishita; Hidesaku Asakura
Journal:  Biomed Rep       Date:  2021-11-22

4.  Downregulation of TRPC4 and TRPC5 Inhibits Smooth Muscle Cell Proliferation without Affecting Endothelial Cell Proliferation.

Authors:  Wenjun Zeng; Yinan Ji; Haiping Zhang; Liusheng Chen; Li Du; Ruiwei Guo
Journal:  Genet Res (Camb)       Date:  2021-11-27       Impact factor: 1.588

Review 5.  The Role of RASGRP2 in Vascular Endothelial Cells-A Mini Review.

Authors:  Jun-Ichi Takino; Shouhei Miyazaki; Kentaro Nagamine; Takamitsu Hori
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

6.  An Integrated Approach Based on Network Analysis Combined With Experimental Verification Reveals PI3K/Akt/Nrf2 Signaling Is an Important Way for the Anti-Myocardial Ischemia Activity of Yi-Qi-Tong-Luo Capsule.

Authors:  Huxinyue Duan; Meiyan Li; Jia Liu; Jiayi Sun; Chunjie Wu; Yu Chen; Xiaohui Guo; Xinglong Liu
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

Review 7.  Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis.

Authors:  Haikun Liu; Geoffrey Pietersz; Karlheinz Peter; Xiaowei Wang
Journal:  J Nanobiotechnology       Date:  2022-02-08       Impact factor: 10.435

8.  Knockdown of long non-coding RNA plasmacytoma variant translocation 1 relieves ox-LDL-induced endothelial cell injury through regulating microRNA-30c-5p in atherosclerosis.

Authors:  Geng Li; Wenxia Zong; Lei Liu; Juan Wu; Jing Pang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 9.  Hypercholesterolemia and Lymphatic Defects: The Chicken or the Egg?

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  Front Cardiovasc Med       Date:  2021-06-23

10.  Antiepileptic Effects of Cicadae Periostracum on Mice and Its Antiapoptotic Effects in H2O2-Stimulated PC12 Cells via Regulation of PI3K/Akt/Nrf2 Signaling Pathways.

Authors:  Qing Zhang; Ruo-Lan Li; Ting Tao; Jia-Yi Sun; Jia Liu; Ting Zhang; Wei Peng; Chun-Jie Wu
Journal:  Oxid Med Cell Longev       Date:  2021-07-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.